COMBINAISONS PHARMACEUTIQUES COMPRENANT UN INHIBITEUR D'HISTONE DÉSACÉTYLASE ET UN INHIBITEUR DU LIGAND DE MORT CELLULAIRE PROGRAMMÉE 1 (PD-L1) ET LEURS MÉTHODES D'UTILISATION

• 收藏
• 分享

专利权人:

Acetylon Pharmaceuticals; Inc.

发明人:

申请号：

EP17873719.3

公开号：

EP3544600A4

申请日:

2017.11.21

申请国别(地区):

EP

年份:

2020

代理人:

摘要：

The present disclosure relates to a pharmaceutical combination comprising (a) a histone deacetylase 6 inhibitor and (b) a programmed death ligand 1 (PD-L1) inhibitor, including combined preparations and pharmaceutical compositions thereof； uses of such combination in the treatment or prevention of cancer； and methods of treating or preventing cancer in a subject comprising administering a therapeutically effective amount of such combination.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/